Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 68,578 | -603,573 | -201,303 | 169,325 | 209,426 |
| Depreciation Amortization | 244,065 | 250,106 | 153,685 | 50,521 | 36,071 |
| Income taxes - deferred | N/A | 371,716 | -9,439 | 742 | 121 |
| Accounts receivable | 17,199 | -133,665 | 100,012 | 43,463 | -122,175 |
| Other Working Capital | -61,318 | -120,217 | -894 | -1,048 | -152,152 |
| Other Operating Activity | 110,477 | 237,338 | 208,169 | -28,816 | 143,769 |
| Operating Cash Flow | $379,001 | $1,705 | $250,230 | $234,187 | $115,060 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -61,836 | -47,181 | -57,744 | -94,771 | -122,756 |
| Net Acquisitions | -251,360 | 34,834 | -324,634 | 15,717 | N/A |
| Sale Of Investment | N/A | 43,017 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -4,350 | -50,250 | -14,000 | -19,500 | -1,850 |
| Other Investing Activity | -4,350 | -50,250 | -14,000 | -19,500 | -1,850 |
| Investing Cash Flow | $-317,546 | $-19,580 | $-396,378 | $-98,554 | $-124,606 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 180,000 | N/A | 1,325,383 | 250,000 | 225,000 |
| Debt Repayment | -37,012 | -29,270 | -617,294 | -13,899 | -11,396 |
| Common Stock Issued | 321 | 1,400 | 3,797 | N/A | N/A |
| Other Financing Activity | -11,502 | -17,963 | -424,211 | -331,116 | -233,099 |
| Financing Cash Flow | $131,807 | $-45,833 | $287,675 | $-95,015 | $-19,495 |
| Exchange Rate Effect | 1,037 | -2,249 | -670 | -242 | 1,481 |
| Beginning Cash Position | 152,822 | 218,779 | 77,922 | 37,546 | 65,106 |
| End Cash Position | 347,121 | 152,822 | 218,779 | 77,922 | 37,546 |
| Net Cash Flow | $194,299 | $-65,957 | $140,857 | $40,376 | $-27,560 |
| Free Cash Flow | |||||
| Operating Cash Flow | 379,001 | 1,705 | 250,230 | 234,187 | 115,060 |
| Capital Expenditure | -61,836 | -47,181 | -83,088 | -94,771 | -122,756 |
| Free Cash Flow | 317,165 | -45,476 | 167,142 | 139,416 | -7,696 |